Melitracenhydrochlorideisanclinicallyacceptableeffectivetricyclicantidepressantthatexertsnoharmfulcardiacsideeffects,unlikemanyotherantidepressants.ThiscompoundisoftenadmiNISTeredwithflupenthixolas“deanxit,”whichshowsefficacyinthetreatmentoftrigeminalneuralgiaandincreasesqualityofliferatingsinsubjectswithfunctionaldyspepsia.ThiscompoundislikelyanantagonistatD1/2receptors.
| CasNo. | 10563-70-9 |
|---|---|
| Purity | ≥99% |
| Formula | C21H25N•HCl |
| FormulaWt. | 327.89 |
| IUPACName | 3-(10,10-dimethylanthracen-9-ylidene)-N,N-dimethylpropan-1-amine;hydrochloride |
| MeltingPoint | 245-248°C |
| Appearance | Whitepowder |
| StoreTemp | Ambient |
|---|---|
| ShipTemp | Ambient |
| InfoSheet | M1845InfoSheetPDF |
|---|
LiuEJ,ZhangWL,BaiYP.[Observationonclinicalefficacyofdepressiontreatedwiththeallianceofacupunctureandmedication].ZhongguoZhenJiu.2013Jun;33(6):497-500.PMID:23967634.
HashashJG,ABDul-BakiH,AzarC,etal.Clinicaltrial:arandomizedcontrolledcross-overstudyofflupenthixol+melitraceninfunctionaldyspepsia.AlimentPharmacolTher.2008Jun1;27(11):1148-55.PMID:18331614.
BinYaacobH.FlupenthixolandMelitraceninthemanagementoftrigeminalneuralgia.DentJMalays.1985Apr;8(2):37-8.PMID:3917005.
MartiniC,FiciF.Acutepoisoningwithmelitracen--absenceofECGchanges.IntJClinPharmacolBiopharm.1978Mar;16(3):129-31.PMID:649231.
